Estadístiques de Palbociclib combined with endocrine therapy in heavily pretreated HR +/HER2 - advanced breast cancer patients: results from the compassionate use program in Spain (PALBOCOMP)
Visites totals
| views | |
|---|---|
| Palbociclib combined with endocrine therapy in heavily pretreated HR +/HER2 - advanced breast cancer patients: results from the compassionate use program in Spain (PALBOCOMP) | 90 |
Visites totals per mes
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| manso-bre-palb.pdf | 42 |
| manso-bre-palb.pdf(legacy) | 41 |
Vistes principals per país
| views | |
|---|---|
| United States | 67 |
| Sweden | 9 |
| Canada | 3 |
| Australia | 2 |
| China | 2 |
| Spain | 2 |
| Argentina | 1 |
| Belgium | 1 |
| Ireland | 1 |
| India | 1 |
| Italy | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 25 |
| Ann Arbor | 7 |
| Boardman | 7 |
| Fairfield | 7 |
| Cambridge | 5 |
| Ashburn | 3 |
| Toronto | 3 |
| Dearborn | 1 |
| Gavá | 1 |
| Menlo Park | 1 |
| Milan | 1 |
| Mountain View | 1 |
| Noida | 1 |
| Portland | 1 |
| Redwood City | 1 |
| Rochester | 1 |
| Sacramento | 1 |
| Shenzhen | 1 |
| Suipacha | 1 |